- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Panacea Biotec Ltd (PNCA)
Panacea Biotec Ltd stock price live, this page displays NSE PNCA stock exchange data. View the PNCA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Panacea Biotec Ltd real time stock price chart below.
What Is the Panacea Biotec Ltd Stock Price Today?
The Panacea Biotec Ltd stock price today is 557.20.
What Is the Stock Symbol for Panacea Biotec Ltd?
The stock symbol for Panacea Biotec Ltd is "PNCA."
What Stock Exchange Does Panacea Biotec Ltd Trade On?
Panacea Biotec Ltd is listed and trades on the NSE stock exchange.
Is Panacea Biotec Ltd a Good Stock to Buy?
Determining whether Panacea Biotec Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PNCA quote. (ISIN: INE922B01023)
What Is the Panacea Biotec Ltd Stock Price Today?
The Panacea Biotec Ltd stock price today is 557.20.
What Is the Stock Symbol for Panacea Biotec Ltd?
The stock symbol for Panacea Biotec Ltd is "PNCA."
What Stock Exchange Does Panacea Biotec Ltd Trade On?
Panacea Biotec Ltd is listed and trades on the NSE stock exchange.
Is Panacea Biotec Ltd a Good Stock to Buy?
Determining whether Panacea Biotec Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PNCA quote. (ISIN: INE922B01023)
557.20
+1.15(+0.21%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
543.80
581.00
52 wk Range
292.40
647.00
PNCA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
543.80581.00
52 wk Range
292.40647.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PNCA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
May 30, 2026
EPS / Forecast
0.08 / --
Revenue / Forecast
1.69B / --
Compare PNCA to Peers and Sector
Metrics to compare | PNCA | Peers Peers - average of corresponding metrics from companies closely matching PNCA: 1762, MANKIND, ZYDUSLIFE, GLENMARK, ABBOTINDIA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPNCAPeersSector |
|---|---|---|---|---|
P/E Ratio | −634.2x | 28.2x | −0.4x | |
PEG Ratio | −17.85 | 1.49 | 0.00 | |
Price/Book | 4.1x | 4.8x | 2.6x | |
Price / LTM Sales | 5.3x | 4.2x | 3.0x | |
Upside (Analyst Target) | - | 9.7% | 56.2% | |
Fair Value Upside | Unlock | 6.4% | 8.9% | Unlock |
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, Mpox, and hepatitis A vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Panacea Biotec (PNCA) Stock Price Today?
The Panacea Biotec stock price today is 557.20 INR.
What Stock Exchange Does Panacea Biotec Trade On?
Panacea Biotec is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Panacea Biotec?
The stock symbol for Panacea Biotec is "PNCA."
What Is the Panacea Biotec Market Cap?
As of today, Panacea Biotec market cap is 34.13B INR.
What Is Panacea Biotec's Earnings Per Share (TTM)?
The Panacea Biotec EPS (TTM) is -0.88.
From a Technical Analysis Perspective, Is PNCA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Panacea Biotec Stock Split?
Panacea Biotec has split 0 times.
How Many Employees Does Panacea Biotec Have?
Panacea Biotec has 2149 employees.
What is the current trading status of Panacea Biotec (PNCA)?
As of Jun 26, 2026, Panacea Biotec (PNCA) is trading at a price of 557.20 INR, with a previous close of 556.05 INR. The stock has fluctuated within a day range of 543.80 INR to 581.00 INR, while its 52-week range spans from 292.40 INR to 647.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.